Ignite Creation Date:
2024-05-05 @ 11:37 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00093639
Status:
COMPLETED
Last Update Posted:
2013-05-01
First Post:
2004-10-06
Brief Title:
Everolimus and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission After Previous Imatinib Mesylate
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-08
Start Date Type:
None
Primary Completion Date:
2006-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-08
Completion Date Type:
ACTUAL
First Submit Date:
2004-10-06
First Submit QC Date:
October 7 2004
Study First Post Date:
2004-10-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-04-30
Last Update Post Date:
2013-05-01
Last Update Post Date Type:
ESTIMATED